Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
Treatment of T2D was considerably heterogenous by HbA1C level and CKD severity in patients with incident CKD. Current agents may not sufficiently fulfill the unmet need of T2D management in patients with CKD.
Authors
- Glen James (ORCID: https://orcid.org/0000-0003-0080-3156)
- Scott C. Beeman (ORCID: https://orcid.org/0000-0001-6721-1185)
- Alain Gay (ORCID: https://orcid.org/0000-0002-0689-7168)
- David Vizcaya (ORCID: https://orcid.org/0000-0003-0248-7636)
- Nikolaus G. Oberprieler
- Xuanhao He (ORCID: https://orcid.org/0000-0003-2310-4120)
- Keith A. Betts (ORCID: https://orcid.org/0000-0002-3088-7453)
- Aozhou Wu (ORCID: https://orcid.org/0000-0001-7066-0408)
Institutions
- Bayer (Germany) (DE)
Publication Details
- Journal
- The American Journal of Managed Care
- Published
- 2024-09-01
- DOI
- https://doi.org/10.37765/ajmc.2024.89599
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00